| USGOV-DEPARTMENT-OF-VETERANS-AFFAIRS |
USGOV-DEPARTMENT-OF-VETERANS-AFFAIRS |
95%
|
USAspending awards from Department of Veterans Affairs: $128,043 across 6 awards. 36C26325P0830 PROSTHETICS. NSC SURGICAL IMPLANT LEFT EYE IDOSE ISENT; 36C26325P0829 PROSTHETICS. SURGICAL IMPLANT RIG… |
| AMBULATORY-SURGERY-CENTERS |
AMBULATORY-SURGERY-CENTERS |
90%
|
Our primary customers include ambulatory surgery centers (ASC), hospitals and physician private practices. |
| HOSPITALS |
HOSPITALS |
90%
|
Our primary customers include ambulatory surgery centers (ASC), hospitals and physician private practices. |
| PHYSICIAN-PRIVATE-PRACTICES |
PHYSICIAN-PRIVATE-PRACTICES |
90%
|
Our primary customers include ambulatory surgery centers (ASC), hospitals and physician private practices. |
| JNJ |
Johnson & Johnson |
72%
|
Reciprocal relationship from JNJ graph: Reciprocal relationship from GKOS graph: compete with many companies, including divisions of companies much larger than us that may have greater resources and … |
| JNJ |
Johnson & Johnson |
72%
|
compete with many companies, including divisions of companies much larger than us that may have greater resources and name recognition, and smaller companies that compete against specific products or… |
| NVSEF |
Novartis AG |
72%
|
compete with many companies, including divisions of companies much larger than us that may have greater resources and name recognition, and smaller companies that compete against specific products or… |
| NVSEF |
Novartis AG |
72%
|
Reciprocal relationship from NVSEF graph: Reciprocal relationship from GKOS graph: Reciprocal relationship from NVSEF graph: Reciprocal relationship from GKOS graph: Reciprocal relationship from NVSE… |
| REGN |
Regeneron Pharmaceuticals, Inc. |
72%
|
compete with many companies, including divisions of companies much larger than us that may have greater resources and name recognition, and smaller companies that compete against specific products or… |
| REGN |
Regeneron Pharmaceuticals, Inc. |
72%
|
Reciprocal relationship from REGN graph: Reciprocal relationship from GKOS graph: compete with many companies, including divisions of companies much larger than us that may have greater resources and… |
| ABBVIE-INC-ALCON-INC |
ABBVIE-INC-ALCON-INC |
62%
|
panies, including divisions of companies much larger than us that may have greater resources and name recognition, and smaller companies that compete against specific products or in certain geographi… |
| ABBVIE-INC-NOVARTIS-AG-GENENTECH-ROCHE-REGENERON |
ABBVIE-INC-NOVARTIS-AG-GENENTECH-ROCHE-REGENERON |
62%
|
panies, including divisions of companies much larger than us that may have greater resources and name recognition, and smaller companies that compete against specific products or in certain geographi… |
| BAYER-AG |
BAYER-AG |
62%
|
panies, including divisions of companies much larger than us that may have greater resources and name recognition, and smaller companies that compete against specific products or in certain geographi… |
| HEALTH-RESOURCES |
HEALTH-RESOURCES |
62%
|
Medicaid, we are required to participate in the MDRP with respect to all of our pharmaceutical products. Participation in the MDRP requires us to calculate and report certain pricing metrics to the g… |
| QUALITY-INTERNAL-AUDIT-INFORMATION-SECURITY-BUSI |
QUALITY-INTERNAL-AUDIT-INFORMATION-SECURITY-BUSI |
62%
|
ke to respond to and recover from cybersecurity incidents, which include processes to triage, assess severity of, escalate, contain, investigate, and remediate the incident, as well as to comply with… |
| SANTEN-PHARMACEUTICAL-CO-LTD |
SANTEN-PHARMACEUTICAL-CO-LTD |
62%
|
Item 1A of this report. This summary should be read in conjunction with the “Risk Factors” section and should not be relied upon as an exhaustive summary of the material risks facing our business. In… |
| STUART-THERAPEUTICS-INC |
STUART-THERAPEUTICS-INC |
62%
|
that is generally proportionate to the increase in net sales for the corresponding period, offset by certain new product launch manufacturing costs associated with iDose TR along with an inventory wr… |
